Thalidomide and Dacarbazine for Metastatic Melanoma

NCT00006200 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

NIH

Sponsor class

Conditions

Melanoma

Interventions

DRUG: thalidomide
DRUG: dacarbazine

Sponsor

National Center for Research Resources (NCRR)